AstraZeneca chief hits back at ‘armchair generals’ after criticism

Pascal Soriot defends firm and says its booster jab has performed well against new Covid variants in trials

• Coronavirus - latest updates
• See all our coronavirus coverage

The chief executive of AstraZeneca has defended the company against armchair generals" and said its vaccine has a future.

Pascal Soriot disclosed the UK had priority access to the jab in a deal with Oxford University in return for investment and that it was only slightly less effective against the India variant than the strain identified in Kent.